Sponsor:
Centre for Addiction and Mental Health
Code:
NCT05142735
Conditions
Prodromal Schizophrenia
Eligibility Criteria
Sex: All
Age: 16 - 35
Healthy Volunteers: Not accepted
Interventions
N-Acetylcysteine
Placebo
Brief summary:
Conditions
Prodromal Schizophrenia
Study ID
NCT05142735
Start date
Jan 13, 2023
Status verified date
Mar, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Nov 1, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 16 - 35
Healthy Volunteers: Not accepted
Enrollment
90 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Experimental
placebo comparator: Placebo Comparator
Interventions
N-Acetylcysteine
Placebo
Primary outcome measure
Central contacts
Locations
Centre for Addiction and Mental Health
Recruiting
Toronto, Ontario, Canada, M5T 1R8
Contacts
Michael Kiang
michael.kiang@camh.caSponsor
Centre for Addiction and Mental Health
Last update posted
Mar 27, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Centre for Addiction and Mental Health on 2026-03-27.